CDMO Activity Tracker: Lupin’s CDMO commissions oncology block in India; Cambrex, Axplora, Hovione expand operations

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

ARMONAIR RESPICLICK

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

79 API Suppliers, 30 USDMF, 30 CEP/COS, 6 JDMF, 6 EU WC, 2 KDMF, 26 NDC API, 48 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

225 Drugs in Development

225 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1082 FDF Dossiers, 73 FDA Orange Book, 793 Europe, 33 Canada, 76 Australia, 53 South Africa, 54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SPRAY, METERED;NASAL - 0.05MG/SPRAY, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.25MG/INH, POWDER;INHALATION - 0.03MG/INH, POWDER;INHALATION - 0.055MG/INH, POWDER;INHALATION - 0.113MG/INH, POWDER;INHALATION - 0.232MG/INH, POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.044MG/INH, AEROSOL, METERED;INHALATION - 0.11MG/INH, AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 2 SPI Pharma, 3 DKSH, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 6 Kirsch Pharma, 10 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 11 BASF, 1 CD Formulation, 5 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 1 Ingredion Pharma Solutions, 12 Kerry, 3 Keval Exports, 1 Kima Chemical, 10 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 10 Roquette, 8 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Fillers, Diluents & Binders, 25 Thickeners and Stabilizers, 21 Solubilizers, 19 Topical, 19 Parenteral, 17 Direct Compression, 15 Granulation, 14 Disintegrants & Superdisintegrants, 10 Emulsifying Agents, 10 Co-Processed Excipients, 8 Rheology Modifiers, 8 Controlled & Modified Release, 7 Surfactant & Foaming Agents, 7 Film Formers & Plasticizers, 5 Coating Systems & Additives, 4 Chewable & Orodispersible Aids, 4 Taste Masking, 1 Lubricants & Glidants, 1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 143 News #PharmaBuzz

GLOBAL SALES INFORMATION

30 US Medicaid Prescriptions, 141 Regulatory FDF Prices, 14 Annual Reports

MARKET PLACE

18 APIs, 5 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

174 US Patents, 11 US Exclusivities, 97 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 8 USP, 19 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
29/11/2025	EUROAPI	France	EUROAPI FRANCE	303MF10172	Fluticasone propionate	2021-12-09	2021-12-09	15 rue Traversie(')re 75012 Paris France
29/11/2025	Seqens	France	Wavelength Enterprises Ltd	218MF10834	Fluticasone propionate	2006-10-20	2021-05-13	Ofer Park, Building E, 5th floor, 94 Shlomo Shmeltzer Road, POB 3158, Petah Tikva 4970602, Israel

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

ARMONAIR RESPICLICK

ARMONAIR RESPICLICK

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

79 API Suppliers

30 USDMF

30 CEP/COS

6 JDMF

6 EU WC

2 KDMF

26 NDC API

48 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

225 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1082 FDF Dossiers

73 FDA Orange Book

793 Europe

33 Canada

76 Australia

53 South Africa

54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY

SPRAY, METERED;NASAL - 0.05MG/SPRAY

POWDER;INHALATION - 0.05MG/INH

POWDER;INHALATION - 0.1MG/INH

POWDER;INHALATION - 0.25MG/INH

POWDER;INHALATION - 0.03MG/INH

POWDER;INHALATION - 0.055MG/INH

POWDER;INHALATION - 0.113MG/INH

POWDER;INHALATION - 0.232MG/INH

POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH

POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH

POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH

LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.044MG/INH

AEROSOL, METERED;INHALATION - 0.11MG/INH

AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Rochem International Inc

2 SPI Pharma

3 DKSH

4 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

6 Kirsch Pharma

10 Actylis

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

11 BASF

1 CD Formulation

5 DFE Pharma

2 Finar

7 Gangwal Chemicals

1 Ideal Cures

1 Ingredion Pharma Solutions

12 Kerry

3 Keval Exports

1 Kima Chemical

10 Microlex e.U

1 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

OINTMENT;TOPICAL - 0.005% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.05MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons